Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Revision consensus osteoporosis].

J H Lockefeer

    Nederlands Tijdschrift Voor Geneeskunde
    |June 20, 1992
    PubMed
    Summary

    Consensus guidelines confirm that oestrogen therapy significantly reduces fracture risk in postmenopausal women. Research continues to explore other osteoporosis treatments like bisphosphonates and anabolic steroids.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Introduction to the pharmacoeconomics of herbal medicines.

    PharmacoEconomics·2000
    Same author

    Reporting format for economic evaluation. Part II: Focus on modelling studies.

    PharmacoEconomics·1998
    Same author

    Reporting format for economic evaluation. Part I: Application to the Dutch healthcare system.

    PharmacoEconomics·1998
    Same author

    [The clinical lesson in the Nederlands Tijdschrift voor Geneeskunde in the last 40 years].

    Nederlands tijdschrift voor geneeskunde·1997
    Same author

    [Bisphosphonates in osteoporosis; a reevaluation].

    Nederlands tijdschrift voor geneeskunde·1996
    Same author

    [What do reviewers look for in 'original articles' submitted for publication in the Nederlands Tijdschrift voor Geneeskunde?].

    Nederlands tijdschrift voor geneeskunde·1996

    Area of Science:

    • Endocrinology
    • Gerontology
    • Pharmacology

    Background:

    • Osteoporosis management guidelines were established in the US (1984) and Netherlands (1985).
    • Key recommendations focused on case finding, prevention, and treatment strategies.
    • The primary conclusion emphasized the efficacy of oestrogen substitution therapy in reducing fractures for postmenopausal women.

    Framework:

    • Established guidelines from 1984/1985 and revised 1991 guidelines consistently support oestrogen therapy.
    • Current understanding of hormonal substitution's impact on cardiovascular disease and specific cancers remains largely unchanged over the past five years.
    • Emerging research highlights the therapeutic potential of alternative osteoporosis treatments.

    Implementation:

    • Oestrogen substitution therapy is a cornerstone treatment for preventing fractures in postmenopausal women.
    • Ongoing evaluation of hormonal replacement therapy considers risks related to cardiovascular disease, breast, and endometrial cancer.
    • Clinical practice is evolving to incorporate newer pharmacological agents.

    Implications:

    • Continued adherence to oestrogen therapy recommendations for fracture prevention in postmenopausal women.
    • Further research into the long-term effects and safety profiles of hormonal therapies.
    • Integration of bisphosphonates and anabolic steroids into comprehensive osteoporosis treatment plans.

    Related Experiment Videos